From the FDA website on "expanded access". (Some
Post# of 72440
"However, when patient enrollment in a clinical trial is not possible (e.g., a patient is not eligible for any ongoing clinical trials, or there are no ongoing clinical trials), patients may be able to receive the product, when appropriate, through expanded acces"
http://www.fda.gov/NewsEvents/PublicHealthFoc...efault.htm